Skip to main content
Erschienen in: Die Kardiologie 4/2018

09.05.2018 | Koronare Herzerkrankung | Journal Club

Omega-3-Fettsäuren und kardiovaskuläres Risiko

verfasst von: S. Müller

Erschienen in: Die Kardiologie | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Auszug

Aung T, Halsey J, Kromhout D et al (2018) Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77,917 individuals. JAMA Cardiol 3(3):225–234 …
Literatur
1.
Zurück zum Zitat Piepolo MF, Hoes AW, Agewal S et al (2016) 2016 guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 37(29):2315–2381CrossRef Piepolo MF, Hoes AW, Agewal S et al (2016) 2016 guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 37(29):2315–2381CrossRef
2.
Zurück zum Zitat American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Epidemiology and Prevention, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Siscovick DS, Barringer TA, Fretts AM et al (2017) Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association. Circulation 135(15):e867–e884CrossRef American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Epidemiology and Prevention, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Siscovick DS, Barringer TA, Fretts AM et al (2017) Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association. Circulation 135(15):e867–e884CrossRef
3.
Zurück zum Zitat GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico) (1999) Dietary supplementation with n‑3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354(9177):447–455CrossRef GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico) (1999) Dietary supplementation with n‑3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354(9177):447–455CrossRef
4.
Zurück zum Zitat Yokoyama M, Origasa H, Matsuzaki M et al (2007) Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369(9567):1090–1098CrossRefPubMed Yokoyama M, Origasa H, Matsuzaki M et al (2007) Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369(9567):1090–1098CrossRefPubMed
Metadaten
Titel
Omega-3-Fettsäuren und kardiovaskuläres Risiko
verfasst von
S. Müller
Publikationsdatum
09.05.2018
Verlag
Springer Medizin
Erschienen in
Die Kardiologie / Ausgabe 4/2018
Print ISSN: 2731-7129
Elektronische ISSN: 2731-7137
DOI
https://doi.org/10.1007/s12181-018-0252-7

Weitere Artikel der Ausgabe 4/2018

Die Kardiologie 4/2018 Zur Ausgabe

Update Cardio

Herzinsuffizienz

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.